ArticleMolecules (Basel, Switzerland)2025
Predicting the Toxicity of Drug Molecules with Selecting Effective Descriptors Using a Binary Ant Colony Optimization (BACO) Feature Selection Approach.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning prediction of bile salt export pump inhibition with Boruta feature selection in imbalanced data.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Predicting the toxicity of drug molecules using in silico quantitative structure-activity relationship (QSAR) approaches is very helpful for guiding safe drug development and accelerating the drug development procedure. The ongoing development of machine learning techniques has made this task easier and more accurate, but it still suffers negative effects from both the severely skewed distribution of active/inactive chemicals and relatively high-dimensional feature distribution. To simultaneously address both of these issues, a binary ant colony optimization feature selection algorithm, called BACO, is proposed in this study. Specifically, it divides the labeled drug molecules into a training set and a validation set multiple times; with each division, the ant colony seeks an optimal feature group that aims to maximize the weighted combination of three specific class imbalance performance metrics (F-measure, G-mean, and MCC) on the validation set. Then, after running all divisions, the frequency of each feature (descriptor) that emerges in the optimal feature groups is calculated and ranked in descending order. Only those high-frequency features are used to train a support vector machine (SVM) and construct the structure-activity relationship (SAR) prediction model. The experimental results for the 12 datasets in the Tox21 challenge, represented by the Modred descriptor calculator, show that the proposed BACO method significantly outperforms several traditional feature selection approaches that have been widely used in QSAR analysis. It only requires a few to a few dozen descriptors for most datasets to exhibit its best performance, which shows its effectiveness and potential application value in cheminformatics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.